Patient-Controlled Therapy with Intravenous Oxycodone in Breathlessness due to Advanced Cancer: A Case Report

Indian J Palliat Care. 2024 Jan-Mar;30(1):77-80. doi: 10.25259/IJPC_84_2023. Epub 2024 Jan 4.

Abstract

Dyspnoea is a debilitating symptom in medicine, especially in palliative care. Opioids are the pharmacological agents of choice in the treatment of dyspnoea in palliative medicine. Morphine is the best-studied opioid, and recent literature on oxycodone is encouraging. In refractory cases, opioid infusion and palliative sedation may have to be used. We present a case that used oxycodone in a patient-controlled device specifically for dyspnoea and its effects in relieving dyspnoea in a fast and timely manner. This helped in meeting the demands of the patient and relieving suffering rapidly with less sedation. This case report is unique in the use of an oxycodone patient-controlled device specifically for dyspnoea.

Keywords: Advanced cancer; Breathlessness; Dyspnoea; Intravenous patient-controlled therapy; Oxycodone.

Publication types

  • Case Reports

Grants and funding

Financial support and sponsorship